Although non-steroidal FXR agonists may be less strongly associated with pruritus, both non-steroidal and steroidal FXR agonists are associated with decreased HDL and decreased low-density lipoprotein (LDL) cholesterol, which is of concern as patients with metabolic liver disease often show increased cardiovascular risk [85]. This evidence concerns the gene NR1H4 and Pruritus.